Navigation Links
Relief Supplies from American Red Cross Arrive in Myanmar
Date:5/11/2008

WASHINGTON, May 11 /PRNewswire-USNewswire/ -- Today, a commercial airplane carrying the first shipment of American Red Cross relief supplies touched down in Yangon, Myanmar, to assist survivors of cyclone Nargis. This newly arrived shipment includes an initial supply of 8,000 insecticide-treated mosquito nets to help prevent the spread of malaria.

"This is a very critical time for survivors, who are exposed to the elements and vulnerable to diseases, like malaria," said David Meltzer, senior vice president, International Services for the American Red Cross. "Our staff and many others in the humanitarian community are working around the clock to provide assistance as quickly as we can."

As of Friday, May 9, three planeloads of supplies from a Red Cross and Red Crescent warehouse in Kuala Lumpur, Malaysia, had arrived in Myanmar, bringing in more than 14 tons of shelter material and other emergency items. These materials, along with stocks from local warehouses-such as hygiene kits, food, water purification tablets, and mosquito nets-are being distributed by the Myanmar Red Cross, who has at least 27,000 volunteers assisting with relief efforts.

"There are considerable challenges to getting relief supplies into the hardest hit areas," said Meltzer. "But this is the priority right now: to get survivors the assistance they need."

So far, the American Red Cross has made available $250,000 in relief supplies, including 10,000 tarps and an additional 12,000 mosquito nets, which will be delivered in the coming days. In addition, the American Red Cross has committed $1.25 million for this relief effort, which includes a pledge of $1 million from the U.S. Agency for International Development's Office of Foreign Disaster Assistance. The American Red Cross will continue to be in close contact with the International Federation of Red Cross and Red Crescent Societies and its other partners to determine further options- including relief items, fi
'/>"/>

SOURCE American Red Cross
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AmeriCares Relief Worker Arrives in Myanmar
2. Direct Reliefs Corporate Partners Key to Aiding Cyclone Victims
3. Simuality Joins Efforts for Myanmar Relief
4. Give2Asia Opens Disaster Recovery Fund for Burma Cyclone Relief Efforts
5. Myanmar Cyclone Relief Fund
6. Aid Urgently Needed in Myanmar (Burma): Lutheran World Relief Responds
7. The HealthCentral Network Signs Spunky Midlife Gals for Comedic Relief on Alzheimers, Skin Care Sites
8. Mix of 2 pain-relief procedures can end chronic back and leg pain without drugs
9. Global Sound Conference Invites Los Angeles Residents to Experience the Latest in Stress Relief with Free Exhibits, Live Music, Movie Screenings and More
10. Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief
11. Relief "In Sight" for Allergy Sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... -- Klafter & Olsen LLP has filed a,class action l..." or the,"Company") (Nasdaq: ARTC ) and certain o...Western District of Texas on behalf of all persons...Care from January 24, 2008,through July 18, 2008 (...,persons or entities who purchased call options or...
(Date:7/25/2008)...etroviral therapy may be due to genetic factors ,...new study challenges the long-held belief that the...,s ability to restore itself after HIV patients ar...y (HAART). , From 50 percent to 90 percent of H... Intravenous drug use is the main cause of both ty...
(Date:7/25/2008)...BeaconEquity.com announces the,availability of Tra... can view all of the daily trading notes for free ... Trade Alerts include: DUSA Pharmaceuticals Inc. (...(Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA), Ado...q: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )., Joi...
(Date:7/25/2008)...ificant Improvements in Members, Health, ATLANTA,... in health,care quality management solutions for h...entered into a long-term agreement with Wellmark, ...on on Quality(SM) Incent and,Reward Best Practices...primary care clinicians to promote improved qualit...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...sociated with cancers, fibrosis and other diseases...say // exposure to asbestos may lay the groundwork... arthritis and multiple sclerosis. Researchers exa... known to be polluted by asbestos. They found thes...
... a frightening experience for children as they oft...ew study shows hypnosis could help reduce distress...re. The study included children who were schedule...y. During a VCUG, a tube is inserted into the blad...
...the poorer quality of life they will have, say res...children participated in the study . Researchers m...rt survey completed by a parent and child self-rep...otional, social and academic functioning of the ch...
...ween fast food consumption and weight gain and ins...eases the risk of obesity and type 2 diabetes. Res...rted fast food habits and changes in bodyweight an...ears. The diets of more than 3,000 young adults we...
Other Medicine News:
(Date:7/22/2008)...ility and Efficacy of Treating Patients with ...NCISCO, and YONGIN-SI, South Korea, July 22 /PRNew...tawa, Ontario), and its South,Korean partner Green...from,a Phase I clinical trial of its first-in-clas...t was well-tolerated and resulted in clear,anti-ca...
(Date:7/22/2008)...tress the Importance to Patients of Passing a ... RICHMOND, Va., July 22 /-...ow-on biologics and biopharmaceuticals, today,anno...ill present at a,Congressional briefing on Friday,...or establishing an approval pathway for follow-on,...
(Date:7/22/2008)... by Columbia University Medical Center Based on ...hnology, The Test Differentiates Squamous From N...lassifying Squamous-Cell Carcinoma of the Lung Wit... of 90 Percent,This is the First CLIA Approved Tes...as Biomarkers for Accurate Diagnosis of Lung Cance...
(Date:7/22/2008)...idual,s Genetic Risk Based on Clinical Data, Pr...al Materials, WALTHAM, Mass., July 22 /PRNewswire...ILI ), today announced the launch of an enhanced t...company,s Heart Health Genetic Test.,The test is c...Heart Health,Genetic Test by Quixtar/Amway. The ne...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Researchers successfully simulate photosynthesis and design a better leaf 1169 1Researchers successfully simulate photosynthesis and design a better leaf 1169 2Researchers successfully simulate photosynthesis and design a better leaf 1169 3Abnormal immune cells may cause unprovoked anaphylaxis 5990 1Abnormal immune cells may cause unprovoked anaphylaxis 5990 2Abnormal immune cells may cause unprovoked anaphylaxis 5990 3Research highlights important indicators of early stage ovarian cancer 5988 1New technology illuminates protein interactions in living cells 1167 1New technology illuminates protein interactions in living cells 1167 2
...ion Therapeutics,announced today that data on two ...prednate) and ST-602 (fenretinide), will be,presen...for,Research in Vision and Ophthalmology (ARVO) in...tions, the company will be hosting a,reception for...ntly being evaluated in two phase,III clinical tri...
...erlying Cause of,Genetic Disorders and Restores Pr...2007 /PRNewswire/ -- New,preclinical data publishe...ure show that PTC124, an investigational new drug,...ious in a,preclinical model of Duchenne muscular d... 13 percent of the cases of DMD are due,to nonsens...
Other Medicine Technology:Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 2Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 3Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 4
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available.
Medicine Products: